Bausch Health Companies Earnings
NYSE: BHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Oct 28, 2026
After market close
Fiscal period
Sep/2026
EPS estimate
$1.08
Bausch Health Companies earnings summary
Bausch Health Companies is scheduled to report Sep/2026 earnings on Oct 28, 2026 after the market closes, with analysts expecting EPS of $1.08. In its most recent report on Jul 30, 2026 (Q2 2026), BHC posted EPS of $0.68. Revenue for the quarter was $2.85 billion.
Quarterly EPS is up 70.0% from the same quarter a year earlier. Across the last 16 reports, BHC shares moved an average of 5.9% (in either direction) in the first trading session after results, rising 5 times and falling 11 times.
Summary generated from market data by MetaCap's automated system. Methodology
BHC earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 30, 2026 | — | $0.68 | — | -9.3% |
| Apr 30, 2026 | — | $-3.82 | — | +1.8% |
| Feb 19, 2026 | — | $-0.30 | — | -3.3% |
| Oct 30, 2025 | — | $0.48 | — | -5.3% |
| Jul 31, 2025 | — | $0.40 | — | +0.7% |
| May 1, 2025 | — | $-0.16 | — | -15.3% |
| Feb 20, 2025 | — | $0.24 | — | +1.8% |
| Oct 31, 2024 | — | $-0.23 | — | -4.5% |
| Aug 1, 2024 | — | $0.03 | — | -3.7% |
| May 2, 2024 | — | $-0.17 | — | -12.0% |
| Feb 22, 2024 | — | $-0.11 | — | +7.7% |
| Nov 2, 2023 | — | $-1.03 | — | -10.0% |
| Aug 3, 2023 | — | $0.07 | — | -7.2% |
| May 4, 2023 | — | $-0.55 | — | -1.9% |
| Feb 23, 2023 | — | $-1.13 | — | -4.3% |
| Nov 3, 2022 | — | $1.10 | — | +6.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.